"Here's How I Knew I Had a Spinal Tumor": One Patient's Journey When Pain Turned Up Elsewhere "Here's How I Knew I Had ALS": A Patient's Story, with an Expert Doctor ...

GLP-1RAs improved RA disease activity, pain scores, weight, cholesterol, and HbA1c levels in patients with a BMI ≥27. Nearly one-third of patients discontinued GLP-1RA therapy due to gastrointestinal ...

Scientists have discovered that rheumatoid arthritis (RA) doesn't start when the pain begins. It silently starts years earlier. RA is a debilitating autoimmune disease that causes painful joint ...

The seven-year study reveals early-warning signs that could help doctors catch the disease before it starts, potentially saving patients years of pain and disability SEATTLE, WASH.—September 24, ...

For more than four years, Lynn Milam's life was bound by the pain that radiated from her swollen joints. "My children could not hug me," she says. "I couldn't hold my husband's hand." Milam also ...

Over one-third of RA patients were frail, with functional disability and lack of exercise as key factors. Frailty prevalence in RA patients is higher than in the general older population, emphasizing ...

Results show that GLP-1s may address rheumatoid arthritis (RA) symptoms, independent of established weight loss and cardiac benefits, by reducing the systemic, chronic inflammation associated with RA.

Past studies have suggested that GLP-1 receptor agonists may inhibit inflammatory processes in addition to their metabolic effects./> This study examined medical records for overweight/obese ...

Rheumatoid arthritis (RA) commonly causes fatigue and pain, stiffness, and swelling in your joints. Roughly 40% of people also experience one or more symptoms in areas outside the joint. These ...